OMNIPODPROMISE
"OMNIPODPROMISE" is a word mark owned by Insulet Corporation, filed at the EUIPO on November 24, 2021. It is registered and covers classes 9, 10 and 35.
- Status
- Registered
- Since July 8, 2022
- Filed
- November 24, 2021
- Registered
- July 7, 2022
- Expires
- November 24, 2031
- Application no.
- 018608426
- Registration no.
- 018608426
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 3 classes
Who owns OMNIPODPROMISE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Insulet Corporation
PODD
Representative
Murgitroyd & Company
Murgitroyd & Company
What the mark covers
The products and services OMNIPODPROMISE is filed for, grouped by Nice class.
Downloadable software in the nature of applications for mobile phone and smart phones providing information and personal medical data relating to diabetes management, insulin, sugar levels and the related data; Downloadable and recorded software and computer hardware for use in insulin monitoring and tracking blood glucose levels; downloadable and recorded software and computer hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded software and computer hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management
Medical devices, including, drug delivery devices, namely, implantable drug delivery pumps and ports, sold empty; smart delivery devices, sold empty, in the nature of implantable drug delivery pumps and ports for communicating with smart devices for data processing; wearable subcutaneous drug delivery devices, sold empty in the nature of injectors, on-body injectors, all sold empty; diabetes management devices, in the nature of blood glucose meters and glucometers, infusion pumps, infusion pump controllers and component parts and attachments thereof
Providing a trade-in and upgrade program for drug delivery and diabetes management devices
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2023/068 Section C.2.1
- Bulletin 2023/062 Section C.2.1
- Bulletin 2022/126 Section B.1
- Bulletin 2022/062 Section A.1
About OMNIPODPROMISE
Who owns the trademark "OMNIPODPROMISE"?
The EUIPO trademark "OMNIPODPROMISE" (application 018608426) is owned by Insulet Corporation.
What is the status of "OMNIPODPROMISE"?
Its status at the EUIPO is: registered.
When was "OMNIPODPROMISE" registered?
It was registered on July 7, 2022 and is due to expire on November 24, 2031.
Get this data via the API
Everything on this page comes from the Signa API. Pull OMNIPODPROMISE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d4475-f3eb-737c-a669-a1337a675b0a
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d4475-f3eb-737c-a669-a1337a675b0a",
"object": "trademark",
"mark_text": "OMNIPODPROMISE",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "018608426",
"filing_date": "2021-11-24",
"nice_classes": [
9,
10,
35
],
"owners": [
{
"name": "Insulet Corporation",
"entity_id": "ent_019eb703-f31b-77f7-9e7b-5b872cd9cb48"
}
]
}